GluR-6 Double Nickase Plasmid (h): sc-402982-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- GluR-6 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- GluR-6 Double Nickase Plasmid (h) and GluR-6 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting GRIK2. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GluR-6 Double Nickase Plasmid (h) | sc-402982-NIC | 20 µg | $410.00 | |||
GluR-6 Double Nickase Plasmid (h2) | sc-402982-NIC-2 | 20 µg | $410.00 |
GRIK2 encodes the kainate-type ionotropic glutamate receptor subunit GluR-6, a ligand-gated cation channel that contributes to fast excitatory neurotransmission and synaptic plasticity in the central nervous system. GluR-6 participates in glutamatergic signaling pathways by regulating Na⁺/K⁺ flux, shaping postsynaptic depolarization, and modulating neurotransmitter release through pre- and postsynaptic receptor complexes. Through activity-dependent signaling and cross-talk with calcium-dependent cascades, GRIK2 influences neuronal development, circuit excitability, and long-term changes in synaptic strength. Genetic and functional variation in GRIK2 has been investigated in relation to neurodevelopmental and neuropsychiatric phenotypes, including altered excitatory–inhibitory balance and susceptibility to seizure-associated network hyperexcitability.
GluR-6 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the GRIK2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within GRIK2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt GRIK2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of GRIK2-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.